TechnoVax, Inc. - Product Pipeline Review - 2013

Market: Pharmaceuticals and Healthcare

Global, 24 pages report, published by Global Markets Direct

Keywords : Current R&D Portfolio of TechnoVax, Inc.; TechnoVax, Inc. - Key Therapeutics; TechnoVax, Inc. - Pipeline Overview and Promising Molecules; TechnoVax, Inc. - News; TechnoVax, Inc. - Latest Updates; TechnoVax, Inc. - Pipeline; TechnoVax, Inc. - Discontinued/Dormant Projects

Report ThumbnailAugust-2013
TechnoVax, Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “TechnoVax, Inc. - Product Pipeline Review - 2013” provides data on the TechnoVax, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, TechnoVax, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from TechnoVax, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- TechnoVax, Inc. - Brief TechnoVax, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TechnoVax, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of TechnoVax, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the TechnoVax, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate TechnoVax, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of TechnoVax, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the TechnoVax, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with TechnoVax, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of TechnoVax, Inc. and identify potential opportunities in those areas.
  • List of Figures
  • TechnoVax, Inc. - Pipeline by Indication, 2013 6
  • TechnoVax, Inc. - Pipeline by Stage of Development, 2013 7
  • TechnoVax, Inc. - Monotherapy Products in Pipeline, 2013 8
  • TechnoVax, Inc. - Pipeline By Therapeutic Class, 2013 18
  • TechnoVax, Inc. - Pipeline By Route of Administration, 2013 20
  • List of Tables
  • TechnoVax, Inc., Key Information 4
  • TechnoVax, Inc., Key Facts 4
  • TechnoVax, Inc. - Pipeline by Indication, 2013 6
  • TechnoVax, Inc. - Pipeline by Stage of Development, 2013 7
  • TechnoVax, Inc. - Monotherapy Products in Pipeline, 2013 8
  • TechnoVax, Inc. - Preclinical, 2013 9
  • TechnoVax, Inc. - Discovery, 2013 10
  • TechnoVax, Inc. - Pipeline By Therapeutic Class, 2013 18
  • TechnoVax, Inc. - Pipeline By Target, 2013 19
  • TechnoVax, Inc. - Pipeline By Route of Administration, 2013 20
  • TechnoVax, Inc. - Dormant Developmental Projects,2013 21
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 3
  • TechnoVax, Inc. Snapshot 4
  • TechnoVax, Inc. Overview 4
  • Key Information 4
  • Key Facts 4
  • TechnoVax, Inc. - Research and Development Overview 5
  • Key Therapeutic Areas 5
  • TechnoVax, Inc. - Pipeline Review 7
  • Pipeline Products by Stage of Development 7
  • Pipeline Products - Monotherapy 8
  • TechnoVax, Inc. - Pipeline Products Glance 9
  • TechnoVax, Inc. - Early Stage Pipeline Products 9
  • Preclinical Products/Combination Treatment Modalities 9
  • Discovery Products/Combination Treatment Modalities 10
  • TechnoVax, Inc. - Drug Profiles 11
  • TVX-001 11
  • Product Description 11
  • Mechanism of Action 11
  • R&D Progress 11
  • TVX-002 12
  • Product Description 12
  • Mechanism of Action 12
  • R&D Progress 12
  • TVX-003 13
  • Product Description 13
  • Mechanism of Action 13
  • R&D Progress 13
  • TVX-004 14
  • Product Description 14
  • Mechanism of Action 14
  • R&D Progress 14
  • TVX-005 15
  • Product Description 15
  • Mechanism of Action 15
  • R&D Progress 15
  • TVX-006 16
  • Product Description 16
  • Mechanism of Action 16
  • R&D Progress 16
  • TVX-007 17
  • Product Description 17
  • Mechanism of Action 17
  • R&D Progress 17
  • TechnoVax, Inc. - Pipeline Analysis 18
  • TechnoVax, Inc. - Pipeline Products by Therapeutic Class 18
  • TechnoVax, Inc. - Pipeline Products By Target 19
  • TechnoVax, Inc. - Pipeline Products by Route of Administration 20
  • TechnoVax, Inc. - Dormant Projects 21
  • TechnoVax, Inc. - Locations And Subsidiaries 22
  • Head Office 22
  • Appendix 23
  • Methodology 23
  • Coverage 23
  • Secondary Research 23
  • Primary Research 23
  • Expert Panel Validation 23
  • Contact Us 24
  • Disclaimer 24

Please select a license type

Share

Related Products

Global Markets DirectTechnoVax, Inc. - Product Pipeline Review - 2013Product ThumbnailTechnoVax, Inc. - Product Pipeline Review - 2013, Industry ReportProduct #: 113362
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved